Table A2:
AMSTAR Scores of Identified Health Technology Assessments and Systematic Reviews
| Author, Year | AMSTAR Scorea | (1) Provided Study Design | (2) Duplicate Study Selection | (3) Broad Literature Search | (4) Considered Status of Publication | (5) Listed Excluded Studies | (6) Provided Characteristics of Studies | (7) Assessed Scientific Quality | (8) Considered Quality in Report | (9) Methods to Combine Appropriate | (10) Assessed Publication Bias | (11) Stated Conflict of Interest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AHRQ, 2004 (Piper et al (37)) | 7 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
| CADTH, 2014b (43) | 6 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
| IHE, 2013 (41) | 10 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Speight et al, 2010 (40) | 6 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
| MUHC, 2014 (Xie et al (42)) | 4 | ✓ | ✓ | ✓ | ✓ |
Abbreviations: AHRQ, Agency for Healthcare Research and Quality; AMSTAR, Assessment of Multiple Systematic Reviews; CADTH, Canadian Agency for Drugs and Technologies in Health; IHE, Institute of Health Economics; MUHC, McGill University Health Centre.
a
Maximum possible score is 11. Details of AMSTAR score are described in Shea et al. (33)
b
Rapid response.